PlainRecalls
FDA Devices Moderate Class II Ongoing

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Reported: February 1, 2023 Initiated: December 15, 2022 #Z-1008-2023

Product Description

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Reason for Recall

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Details

Recalling Firm
Meridian Bioscience Inc
Units Affected
92 kits
Distribution
US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.
Location
Cincinnati, OH

Frequently Asked Questions

What product was recalled?
Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700. Recalled by Meridian Bioscience Inc. Units affected: 92 kits.
Why was this product recalled?
Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2
Which agency issued this recall?
This recall was issued by the FDA Devices on February 1, 2023. Severity: Moderate. Recall number: Z-1008-2023.